35.1 Urinary Anti-infectives

Urinary Anti-infectives

Urinary anti-infectives are medications used to treat or prevent urinary tract infections (UTIs). Because UTIs are among the most common infections nurses encounter, understanding these drugs is essential for safe administration, accurate patient teaching, and recognizing complications early.

This section covers four key urinary anti-infectives: nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), fosfomycin, and methenamine. For each, you'll need to know the clinical use, mechanism, side effects, drug interactions, and nursing considerations.

Key Features and Uses of Common Urinary Anti-infective Drugs

Nitrofurantoin (Macrobid, Macrodantin) is a first-line choice for uncomplicated lower UTIs (cystitis). It concentrates in the urine rather than in systemic tissues, which makes it effective for bladder infections but not appropriate for upper UTIs like pyelonephritis, since it doesn't reach therapeutic levels in the kidneys or bloodstream. It should be taken with food to reduce GI upset.

Trimethoprim-sulfamethoxazole (Bactrim, Septra) combines two antibiotics that work synergistically by blocking folate synthesis at two different steps. It's effective against the most common UTI pathogens, including E. coli, Klebsiella, and Enterobacter. TMP-SMX can be used for both uncomplicated and complicated UTIs, including recurrent infections. Two critical contraindications to remember:

• Sulfa allergy (risk of severe hypersensitivity reactions)
• G6PD deficiency (risk of hemolytic anemia)

Fosfomycin (Monurol) is given as a single oral dose for uncomplicated UTIs, which makes adherence straightforward. It has broad-spectrum activity against both Gram-negative organisms (E. coli) and Gram-positive organisms (Enterococcus). A notable advantage is minimal disruption of normal gut flora, which lowers the risk of C. difficile infection.

Methenamine (Hiprex, Urex) works differently from the others. Rather than being a traditional antibiotic, it converts to formaldehyde in acidic urine, and that formaldehyde is what kills bacteria. It's used for long-term prophylaxis of recurrent UTIs, not for treating active infections. The urine pH must be below 5.5 for the drug to work, so patients may need to take urinary acidifying agents (such as vitamin C) alongside it.

Mechanisms of Action, Side Effects, and Drug Interactions

Nitrofurantoin

• Mechanism: Damages bacterial DNA, RNA, and proteins, disrupting multiple pathways at once. This multi-target approach is why resistance develops slowly.
• Side effects: Nausea, vomiting, headache, and brown discoloration of urine (warn patients this is expected and harmless). With long-term use, watch for pulmonary toxicity (cough, dyspnea) and peripheral neuropathy.
• Drug interactions: Antacids and proton pump inhibitors can decrease absorption. Avoid use with magnesium-containing antacids in particular.

Trimethoprim-sulfamethoxazole

• Mechanism: Inhibits bacterial folate synthesis at two sequential steps (trimethoprim blocks dihydrofolate reductase; sulfamethoxazole blocks dihydropteroate synthase). Bacteria can't make folate, so they can't replicate.
• Side effects: Nausea, vomiting, skin rash, photosensitivity, and hyperkalemia (trimethoprim can block potassium excretion in the kidneys). Monitor potassium levels, especially in patients on ACE inhibitors or potassium-sparing diuretics.
• Drug interactions: Increases the anticoagulant effect of warfarin (monitor INR closely). Increases toxicity of methotrexate (both drugs affect folate metabolism).

Fosfomycin

• Mechanism: Inhibits an early step in bacterial cell wall synthesis, leading to cell lysis and death.
• Side effects: Diarrhea, nausea, vomiting, headache. Generally well tolerated given the single-dose regimen.
• Drug interactions: Metoclopramide increases GI motility and can decrease fosfomycin absorption. Avoid concurrent use.

Methenamine

• Mechanism: In acidic urine (pH < 5.5), methenamine hydrolyzes into formaldehyde, which denatures bacterial proteins. No antibacterial effect occurs if urine is not sufficiently acidic.
• Side effects: Nausea, vomiting, rash, bladder irritation.
• Drug interactions: Antacids and urinary alkalinizers (such as sodium bicarbonate) raise urine pH and directly block the drug's conversion to formaldehyde. These should be avoided. Also avoid use with sulfonamides, as formaldehyde can form an insoluble precipitate with sulfa drugs in the urine.

Essential Nursing Considerations When Administering Urinary Anti-infectives

1. Assess allergy history before administration. Sulfa allergies are especially common and contraindicate TMP-SMX.
2. Encourage adequate fluid intake (at least 2,000 mL/day unless contraindicated) to maintain urine output and help prevent crystalluria, particularly with TMP-SMX.
3. Monitor renal function (BUN, creatinine, GFR). Dose adjustments are often needed for patients with impaired kidney function. Nitrofurantoin is generally avoided when creatinine clearance falls below 30 mL/min because it won't concentrate adequately in the urine and the risk of toxicity increases.
4. Educate patients to complete the full antibiotic course, even if symptoms improve early. Stopping early promotes resistance.
5. Assess for UTI resolution vs. progression. Resolution looks like decreased frequency, urgency, and dysuria. Progression may present as fever, chills, flank pain, or costovertebral angle tenderness, which could indicate the infection has spread to the kidneys.
6. Monitor for adverse reactions such as rash, persistent nausea, or diarrhea. Report new or worsening symptoms to the provider promptly.
7. Time medications appropriately. Nitrofurantoin should be given with food. Fosfomycin is mixed in water and taken on an empty stomach. Check each drug's specific administration guidelines.

Patient Education for Safe and Effective Use

• Take medications exactly as prescribed. Skipping doses or stopping early can lead to treatment failure and antibiotic resistance.
• Drink plenty of water (8 to 10 glasses per day) to flush bacteria from the urinary tract and support drug effectiveness.
• Void frequently and empty the bladder completely. Holding urine allows bacteria to multiply.
• Know the warning signs. Teach patients to contact their provider if they experience persistent or worsening symptoms (fever, flank pain, blood in urine) or adverse reactions (rash, severe GI symptoms, difficulty breathing).
• Practice UTI prevention strategies: wipe front to back after toileting, urinate after intercourse, and avoid irritating products such as douches or scented hygiene sprays.
• For methenamine specifically: patients should avoid urinary alkalinizers and may be advised to take vitamin C or cranberry products to keep urine acidic. Note that alcohol does not cause a true disulfiram-like reaction with methenamine; however, patients should follow provider-specific guidance regarding alcohol use.
• Report all current medications to the provider, including over-the-counter antacids and supplements, to avoid drug interactions (especially with warfarin, methotrexate, and antacids).